Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease

Lupus

Volumn 15, Issue 12, 2006, Pages 865-872

  Scherl, M ^a   Posch, U ^a   Obermoser, G ^a   Ammann, C ^a   Sepp, N ^a   Ulmer, H ^a   Dierich, M P ^a   Stoiber, H ^a   Falkensammer, Barbara ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Auto antibodies; Complement; Human immunodeficiency virus; Neutralization; Systemic lupus eythematosus

Indexed keywords

CROSS REACTING ANTIBODY; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; COMPLEMENT ACTIVATION; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERODIAGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; VIRUS LOAD; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; COMPLEMENT SYSTEM PROTEINS; CONNECTIVE TISSUE DISEASES; CROSS REACTIONS; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; T-LYMPHOCYTES; U937 CELLS; VIRUS REPLICATION;

EID: 33845972991     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203306071405     Document Type: Article

References (54)

1. Kyttaris VC, Juang YT, Tsokos GC. Immune cells and cytokines in systemic lupus erythematosus: an update. Curr Opin Rheumatol 2005; 17: 518-522.
2. Nagy G, Koncz A, Perl A. T- and B-cell abnormalities in systemic lupus erythematosus. Crit Rev Immunol 2005; 25: 123-140.
3. Sekigawa I, Okada M, Ogasawara H et al. Lessons from similarities between SLE and HIV infection. J Infect 2002; 44: 67-72.
4. Abuaf N, Laperche S, Rajoely B et al. Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thrombosis and Haemostasis 1997; 77: 856-861.
5. Kopelman RG, Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 1988; 84: 82-88.
6. Strauss J, Abitbol C, Zilleruelo G et al. Renal disease in children with the acquired immunodeficiency syndrome. New Engl J Med 1989; 321: 625-630.
7. D'Agati V, Seigle R. Coexistence of AIDS and lupus nephritis: a case report. Am J Nephrol 1990; 10: 243-247.
8. Furie RA. Effects of human immunodeficiency virus infection on the expression of rheumatic illnes. Rheum Dis Clin North Am 1991; 17: 177-188.
9. Yeh CK, Fox PC, Goto Y, Austin HA, Brahim JS, Fox CH. Human immunodeficiency virus (HIV) and HIV infected cells in saliva and salivary glands of a patient with systemic lupus erythematosus. J Rheumatol 1992; 19: 1810-1812.
10. Bambery P, Deodhar DD, Malhotra HS, Sehgal S. Blood transfusion related HBV and HIV infection in a patient with SLE. Lupus 1993; 2: 203-205.
11. Itoh K, Nishioka Y, Hirohata S et al. HIV induced systemic lupus erythematosus. Lupus 1994; 3: 205-206.
12. Lu I, Cohen PR, Grossman ME. Multiple dermatofibromas in a woman with HIV infection and systemic lupus erythematosus. J Am Acad Dermatol 1995; 32: 901-903.
13. Maradona JA, Carton CA, Asensi V. Mysthenia gravis and systemic lupus erythematosus in association with human immunodeficiency virus infection. Clin Infect Dis 1995; 20: 1577-1578.
14. Molina JF, Citera G, Rosier D et al Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus. J Rheumatol 1995; 22: 347-350.
15. Byrd VM, Sergent JS. Suppression of systemic lupus erythematosus by the human immunodeficiency virus. J Rheumatol 1996; 23: 1295-1296.
16. Cimmino MA, de Maria A, Moggiana G, Parisi M, Querci G, Accardo S. HIV infection in a male patient with systemic lupus erythematosus. Clin Exp Rheumatol 1996; 14: 317-320.
17. Contreras G, Dollie GF, Pardo V, Schultz DR, Bour-giognie JJ. Systemic lupus erythematosus in two adults with human immunodeficiency virus infection. Am J Kidney Dis 1996; 28: 292-295.
18. Kudva KC, Lynne PS, Holley KE, Wright AJ, Hunder GG. SLE nephropathy in a patient with HIV infection: case report and review of the literature. J Rheumatol 1996; 23: 1811-1815.
19. Fernández-Mirand C, Rubio R, Pulido F. Development of acquired immune deficiency syndrome in a patient with systemic lupus erythemaotusus. J Rheumatol 1996; 23: 1308.
20. Fox FA, Isenberg DA. Human immunodeficiency virus infection in systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1168-1172.
21. Chang BG, Markowitz GS, Seshan SV, Seigle RL, D'Agati VD. Renal manifestations of concurrent systemic lupus erythematosus in HIV infection. Am J Kidney Dis 1999; 33: 441-449.
22. Clutterbuck DJ, Watson J, De Ruiter A, Godfrey T, Bradbeer C. Presence of HIV infection in patients diagnosed with systemic lupus erythematosus. Rheumatology 2000; 39: 1047-1048.
23. Diri E, Lipsky PE, Berggren RE. Emergence of lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection. J Rheumatol 2000; 27: 2711-2714.
24. Calza L, Manfredi R, Colangeli V, D'Antuono A, Passarini B, Chiodo F. Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy. Int J STD AIDS 2003; 14: 356-359.
25. Sommer S, Piyadigamage A, Goodfield MJ. Systemic lupus erythematosus or infection with HIV, or both? Clin Exp Dermatol 2004; 29: 393-395.
26. Palacios R, Santos J, Valdivielso P, Marquez M. Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature. Lupus 2002; 11: 60-63.
27. Daikh BE, Holyst MM. Lupus-specific autoantibodies in concomitant human immunodeficiency virus and systemic lupus erythematosus: case report and literature review. Semin Arthritis Rheum 2001; 30: 418-425.
28. Wanchu A, Sud A, Singh S, Bambery P. Human immunodeficiency virus infection in a patient with systemic lupus erythematosus. J Assoc Physicians India 2003; 51: 1102-1104.
29. Barthel HR, Wallace DJ. False positive human immunodeficiency virus testing in patients with lupus erythematosus. Semin Arthritis Rheum 1993; 23: 1-7.
30. Sekigawa I, Lee S, Kaneko H et al. The possible role of interleukin-16 in the low incidence of HIV infection in patients with systemic lupus erythematosus. Lupus 2000; 9: 155-156.
31. Zangerle R, Steinhuber S, Sarcletti M et al. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals. Int Arch Allergy Immunol 1998; 116: 228-239.
32. Frank I, Stoiber H, Godar S et al. Acquisition of host cell-surface-derived molecules by HIV-I. AIDS 1996; 10: 1611-1620.
33. Purtscher M, Trkola A, Gruber G et al. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1994; 10: 1651-1658.
34. Spruth M, Stoiber H, Kacani L, Schonitzer D, Dierich MP. Neutralization of HIV type 1 by alloimmune sera derived from polytransfused patients. AIDS Res Hum Retroviruses 1999; 15: 533-543.
35. Reveille JD. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Semin Arthritis Rheum 2000; 30: 147-166.
36. Palacios R, Santos J, Valdivielso P, Marquez M. Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature. Lupus 2002; 11: 60-63.
37. Calza L, Manfredi R, Colangeli V, Chiodo F. Systemic lupus erythematosus and HIV infection. A case report and review of the literature. Recenti Prog Med 2002; 93: 28-31.
38. Diri E, Lipsky PE, Berggren RE. Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection. J Rheumatol 2000; 27: 2711-2714.
39. Daikh BE, Holyst MM. Lupus-specific autoantibodies in concomitant human immunodeficiency virus and systemic lupus erythematosus: case report and literature review. Semin Arthritis Rheum 2001; 30: 418-425.
40. Font J, Vidal J, Cervera R et al. Lack of relationship between human immunodeficiency virus infection and systemic lupus erythematosus. Lupus 1995; 4: 47-49.
41. Povolotsky J, Polsky B, Laurence J, Jindal R, Rozon-Solomon M, Burrows L. Withdrawal of conclusion: false positive tests for HIV in a woman with lupus. N Engl J Med 1994; 331: 881-882.
42. Adelman MK, Marchalonis JJ. Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses. Clin Immunol 2002; 102: 107-116.
43. Kaye BR. Rheumatologic manifestations of HIV infections. Clin Rev Allergy Immunol 1996; 14: 385-416.
44. Gonzalez CM, Lopez-Longo FJ, Samson J et al. Antiribonucleoprotein antibodies in children with HIV infection: a comparative study with childhood-onset systemic lupus erythematosus. AIDS Patient Care STDS 1998; 12: 21-28.
45. Rodriguez-Mahou M, Lopez-Longo J, Lapointe N et al. Autoimmune phenomena in children with human immunodeficiency virus infection and acquired immunodeficiency syndrome. Acta Paediatr Suppl 1994; 400: 31-34.
46. Pinto LA, Dalgleish AG, Sumar N, Poulton TA. Panel of anti-gp120 monoclonal antibodies reacts with same nuclear proteins in uninfected cells as those recognized by autoantibodies from patients with systemic lupus erythematosus. AIDS Res Hum Retroviruses 1994; 10: 823-828.
47. Talal N, Garry RF, Schur PH et al. A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest 1990; 85: 1866-1871.
48. Stoiber H, Thielens NM, Ebenbichler C, Arlaud GJ, Dierich MP. The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1 and share antigenic homology. Eur J Immunol 1994; 24: 294-300.
49. Stoiber H, Ebenbichler CF, Schneider R, Janatova J, Dierich MP. Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1. AIDS 1995; 9: 19-26.
50. Golding H, Robey FA, Gates III FT, et al. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J Exp Med 1988; 167: 914-923.
51. Golding H, Shearer GM, Hillman K et al. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J Clin Invest 1989; 83: 1430-1435.
52. Gul A, Inanc M, Yilmaz G et al. Antibodies reactive with HIV-1 antigens in systemic lupus erythematosus. Lupus 1996; 5: 120-122.
53. Wilfingseder D, Spruth M, Ammann CG et al. Complement-mediated enhancement of HIV-1 neutralisation by anti-HLA antibodies derived from polytransfused patients. Int Arch Allergy Immunol 2003; 131: 62-72.
54. Stoiber H, Kacani L, Speth C, Wurzner R, Dierich MP. The supportive role of complement in HIV pathogenesis. Immunol Rev 2001; 180: 168-176.